Senti Biosciences Holdings, Inc.
SNTI
$0.96
-$0.01-0.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.38% | 32.89% | -2.40% | 14.98% | 25.71% |
| Total Depreciation and Amortization | -5.24% | -15.86% | -29.00% | -31.07% | -29.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 627.56% | -145.87% | 1,654.92% | -11.53% | -82.68% |
| Change in Net Operating Assets | -41.36% | -82.20% | -103.57% | -50.20% | 30.14% |
| Cash from Operations | -4.94% | -43.35% | -14.25% | 8.39% | 20.99% |
| Capital Expenditure | -653.85% | -989.47% | 88.97% | 99.80% | 99.78% |
| Sale of Property, Plant, and Equipment | -80.00% | -92.73% | -31.43% | -42.86% | -42.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -641.18% | -233.56% | -100.64% | -99.88% | -99.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -77.21% | 8,341.26% | 8,465.28% | 5,430.89% | 5,430.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.56% | -5.68% | -- | -- | -- |
| Cash from Financing | -78.11% | 1,636.01% | 10,092.68% | 6,449.88% | 6,797.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -357.68% | 105.48% | 127.56% | 229.73% | 157.42% |